China’s SMIC, chipmaking stocks rally on report of advanced AI chip testing
Ainos, Inc. (NASDAQ:AIMD) filed a prospectus supplement with the Securities and Exchange Commission on Friday to offer and sell up to $874,496 of additional shares of its common stock through an at-the-market (ATM) offering agreement with H.C. Wainwright & Co., LLC as placement agent.
According to the company’s SEC filing, Ainos previously entered into the ATM agreement on May 31, 2024, initially authorizing the sale of up to $1,353,197 in common stock. On July 11, 2024, the company increased the aggregate offering price to $1,840,350. Prior to this latest filing, Ainos sold approximately $1,840,337 of common stock under the agreement.
The prospectus supplement filed Friday adds $874,496 in additional shares available for sale under the same agreement. The filing also includes a legal opinion from Lucosky Brookman LLP regarding the validity of the shares issued in connection with the offering.
Ainos’ common stock and warrants to purchase common stock are listed on The Nasdaq Stock Market LLC under the symbols AIMD and AIMDW, respectively.
This information is based on a statement in the company’s SEC filing.
In other recent news, Ainos, Inc. announced a significant three-year subscription-based order valued at $2.1 million with ASE Technology Holding Co., Ltd. This deal involves deploying 1,400 AI Nose units across ASE’s three major manufacturing sites in Taiwan, marking the first commercial application of Ainos’ AI-powered scent digitization platform in semiconductor manufacturing. Additionally, Ainos revealed plans to expand its AI Nose technology through a partnership with ugo, Inc. in Japan. This collaboration will see robots equipped with scent-sensing capabilities deployed across seven industrial sites, including pharmaceutical manufacturing and energy operations.
In another development, Ainos completed a 1-for-5 stock consolidation, which aligns with Nasdaq listing requirements and strengthens the company’s capital structure. The consolidation reduces the number of outstanding shares while increasing the share price proportionally, aiming to attract institutional investors. These recent developments highlight Ainos’ strategic initiatives to scale its AI Nose platforms globally and enhance its market presence.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.